Scaffold attachment region-mediated enhancement retroviral vector expression in primary T cells

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 3720-3728

  Agarwal, Manju ^a   Austin, Timothy W ^a   Morel, Franck ^a   Chen, Jingyi ^a   Böhnlein, Ernst ^a   Plavec, Ivan ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; MOLONEY MURINE SARCOMA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENE; VIRUS DNA CELL DNA INTERACTION; VIRUS EXPRESSION;

EID: 0031958593     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.3720-3728.1998     Document Type: Article

References (36)

1. Blaese, R. M., K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J. J. Greenblatt, S. A. Rosenberg, H. Klein, M. Berger, C. A. Mullen, W. J. Ramsey, L. Muul, R. A. Morgan, and W. F. Anderson. 1995. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 270:475-480.
2. Bode, J., T. Schlake, M. Ríos-Ramírez, C. Mielke, M. Stengert, V. Kay, and W. D. Klehr. 1995. Scaffold/matrix-attachment regions (S/MAR): structural properties creating transcriptionally active loci. Academic Press. Inc., Orlando, Fla.
3. Bonyhadi, M., K. Moss, A. Voytovitch, J. Auten, C. Kalfoglou, I. Plavec, S. Forestell, L. Su, E. Böhnlein, and H. Kaneshima. 1997. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71: 4707-4716.
4. Bordignon, C., L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, P. Servida, A. G. Ugazio, and F. Mavilio. 1995. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immundeficient patients. Science 270:470-475.
5. Boulikas, T. 1993. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J. Cell. Biochem. 52:14-22.
6. Bunnell, B. A., L. Mesler Muul, R. E. Donahue, R. M. Blease, and R. A. Morgan. 1995. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92:7739-7743.
7. Bunnell, B. A., M. Metzger, E. Byrne, R. A. Morgan, and R. E. Donahue. 1997. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89:1987-1995.
8. Burns, J. C., T. Friedmann, W. Driever, M. Burrascano, and J. K. Yee. 1993. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90:8033-8037.
9. Colicelli, J., and S. P. Goff. 1986. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45.
10. Dickinson, L. A., T. Joh, Y. Kohwi, and T. Kohwi-Shigematsu. 1992. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70:631-645.
11. DiGiusto, D. L., R. Lee, J. Moon, K. Moss, T. O'Toole, A. Voytovich, D. Webster, and J. J. Mulé. 1996. Hematopoietic potential of cryopreserved and ex vivo manipulated cord blood progenitors evaluated in vitro and in vivo. Blood 87:1261-1271.
12. Forestell, S. P., E. Böhnlein, and R. J. Rigg. 1995. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production. Gene Ther. 2:723-730.
13. Hantzopoulos, P. A., B. A. Sullenger, G. Ungers, and E. Gilboa. 1989. Improved gene expression upon transfer of the adenosine deaminase minigene outside the transcriptional unit of a retroviral vector. Proc. Natl. Acad. Sci. USA 86:3519-3523.
14. Hawley, R. G., A. Z. C. Fong, B. F. Burns, and T. S. Hawley. 1992. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J. Exp. Med. 176:1149-1164.
15. Jang, S. K., M. V. Davies, R. J. Kaufman, and E. Wimmer. 1989. Initiation of protein synthesis by internal entry of ribosomes into 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63:1651-1660.
16. Jenuwein, T., W. C. Forrester, L. A. Fernández-Herrero, G. Laibe, M. Dull, and R. Grosschedl. 1997. Extension of chromatin accessibility by nuclear matrix attachment regions. Nature 385:269-272.
17. Jolly, D. 1994. Viral vector system for gene therapy. Cancer Gene Ther. 1:51-64.
18. Junker, U., E. Böhnlein, and G. Veres. 1995. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy. Gene Ther. 2:639-646.
19. Kalos, M., and R. E. K. Fournier. 1995. Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell. Biol. 15:198-207.
20. Klehr, D., K. Maass, and J. Bode. 1991. Scaffold-attached regions from the human Interferon β domain can be used to enhance stable expression of genes under the control of various promoters. Biochemistry 30:1264-1270.
21. Malim, M. H., S. Böhnlein, J. Hauber, and B. R Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58:205-214.
22. McKnight, R. A., A. Shamay, L. Sankaran, R. J. Wall, and L. Hennighausen. 1992. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc. Natl. Acad. Sci. USA 89:6943-6947.
23. Mielke, C., Y. Kohwi, T. Kohwi-Shigematsu, and J. Bode. 1990. Hierarchical binding of DNA fragments derived from scaffold-attached regions: correlation of properties in vitro and function in vivo. Biochemistry 29:7475-7485.
24. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-990.
25. Namikawa, R., K. N. Weilbaecher, H. Kaneshima, E. J. Yee, and J. M. McCune. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172:1055-1063.
26. Plavec, I., M. Agarwal, K. E. Ho, M. Pineda, J. Auten, J. Baker, H. Matsuzaki, S. Escaich, M. Bonyhadi, and E. Böhnlein. 1997. High trans-dominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS. Gene Ther. 7:128-139.
27. Plavec, I., A. Voytovich, K. Moss, O. Webster, M. B. Hanley, S. Escaich, K. E. Ho, E. Böhnlein, and D. L DiGiusto. 1996. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. Gene Ther. 3:717-724.
28. Poljak, L., C. Seum, T. Mattiooi, and U. K. Laemmli. 1994. SARs stimulate but do not confer position independent gene expression. Nucleic Acids Res. 22:4386-4394.
29. Rigg, J. R., J. Chen, J. S. Dando, S. P. Forestall, I. Plavec, and E. Böhnlein. 1996. A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety. Virology 218:290-295.
30. So, L., R. Lee, M. Bonybadi, H. Matsuzaki, S. Forestall, S. Escaich, E. Böhnlein, and H. Kaneshima. 1997. Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro. Blood 89:2283-2290.
31. Tagawa, M., L. Nakauchi, L. A. Herzenberg, and G. P. Nolan. 1986. Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation. Proc. Natl. Acad. Sci. USA 83:3422-3426.
32. Thompson, E. M., E. Christians, M.-G. Stinnakre, and J.-P. Renard. 1994. Scaffold attachment region stimulate HSP70.1 expression in mouse preimplantation embryos but not in differentiated tissues. Mol. Cell. Biol. 14:4694-4703.
33. + T lymphocytes by retroviral vectors expressing anti-HIV genes. J. Virol. 69:4045-4052.
34. Woffendin, C., U. Ranga, Z.-Y. Yang, L. Xu, and G. J. Nabel. 1996. Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. USA 93:2889-2894.
35. Woffendin, C., Z. Y. Yang, R. Udaykumar, L. Xu, N. S. Yang, M. J. Sheehy, and G. J. Nabel. 1994. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc. Natl. Acad. Sci. USA 91:11581-11585.
36. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.